logo
Select company
Select metric
$ 10.84MInvested Capital
VS
Market
12
Sector
21
Industry
13
History
80
$ 5.33Close
$ 1.36 - $ 5.68 52-Week Range
Ticker Information

Ticker

NEPH

Company Name

NEPHROS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

NEPHROS INC - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NEPH - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 1.24M$ 9.6M$ 10.84M
3/31/2025$ 1.33M$ 9.29M$ 10.62M
12/31/2024$ 1.41M$ 8.59M$ 10M
9/30/2024$ 1.49M$ 8.17M$ 9.67M
6/30/2024$ 1.58M$ 7.93M$ 9.51M
3/31/2024$ 1.71M$ 8.18M$ 9.89M
12/31/2023$ 1.84M$ 8.36M$ 10.19M
9/30/2023$ 780K$ 8.62M$ 9.4M
6/30/2023$ 857K$ 8.65M$ 9.51M
3/31/2023$ 931K$ 8.89M$ 9.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEPHROS INC's latest trailing twelve months (TTM) Inv. Capital stands at $ 10.7M.
  • Over the past 5 years, NEPHROS INC's average Inv. Capital has been $ 10.67M.
  • The median Inv. Capital for NEPHROS INC during this period was $ 10.15M
  • NEPHROS INC reached its highest Inv. Capital over the past 5 years at $ 14.7M.
  • The lowest Inv. Capital recorded by NEPHROS INC in the same timeframe $ 6.68M

NEPHROS INC's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
POCI : PRECISION OPTICS CORPORATION INC $ 14.3MNXGL : NEXGEL INC $ 7.33MEKSO : EKSO BIONICS HOLDINGS INC $ 16.32MVVOS : VIVOS THERAPEUTICS INC $ 16.16MXLO : XILIO THERAPEUTICS INC $ 14.63MFEMY : FEMASYS INC $ 9.36MMLSS : MILESTONE SCIENTIFIC INC $ 4.43MGBIO : GENERATION BIO CO $ 139.43MPRPO : PRECIPIO INC $ 14.9MBNGO : BIONANO GENOMICS INC $ 64.95M

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for NEPHROS INC is calculated as follows: Debt [ $ 2.31M ] + Equity [ $ 8.39M ]
(=) Inv. Capital [ $ 10.7M ]

NEPH - Invested Capital, Last 5 years

$ 6.68M

Minimum

Dec 31, 2022

$ 14.7M

Maximum

Dec 31, 2020

$ 10.67M

Average

$ 10.15M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 760.7M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 760.7M
median$ 303.53M
std$ 1B